National Emerging Infectious Diseases Laboratories Operations07/08/2021 - 06/30/2026 (Key Person)
PI:
Ronald B. Corley, PhDNIH/National Institute of Allergy & Infectious Diseases2UC7AI095321-08
Midwest AViDD Center - CORE E05/16/2022 - 04/30/2025 (Subcontract PI)
Regents of the University of Minnesota NIH NIAID1U19AI171954-01
Center for Antiviral Medicines & Pandemic Preparedness (CAMPP) - PROJECT 605/16/2022 - 04/30/2025 (Subcontract PI)
The Scripps Research Institute NIH NIAID1U19AI171443-01
Perturbing virus replication with interfering peptides04/25/2022 - 03/31/2024 (Subcontract PI)
Purdue University NIH NIAID1R21AI166736-01
Assay development and execution of live virus testing in support of the Harvard-AbbVie Research Collaboration03/01/2021 - 02/28/2024 (Subcontract PI)
President & Fellows of Harvard College on behalf of Harvard Medical School AbbVie
Evaluation of SARS-COV-2 nuclease conjugates for treatment in the rodent model of SARS-COV-2 disease07/01/2021 - 12/31/2023 (PI)
Massachusetts Institute of Technology
STTR Phase I: Aminomethyl benzamides as novel anti Ebola agents08/16/2019 - 07/31/2023 (Subcontract PI)
Chicago BioSolutions, Inc. NIH NIAID5R42AI126971-04
Antiviral Lead Identification to Treat Filovirus Infections08/12/2019 - 07/31/2023 (Subcontract PI)
Purdue University NIH NIAID5R01AI128364-04
Modeling Filovirus Infection of and Trafficking through Skin08/01/2018 - 07/31/2023 (Subcontract PI)
The University of Iowa NIH NIAID5 R01 AI134733-04
Investigation of the role of phosphatidic acid metabolism in filovirus budding03/01/2021 - 02/28/2023 (Subcontract PI)
Purdue University NIH NIAID5R21AI142651-02
Showing 10 of 19 results.
Show All Results
Small molecule inhibitors of Ebola virus polymerase function02/01/2022 - 01/31/2023 (Subcontract PI)
Icahn School of Medicine at Mount Sinai NIH NIAID7R01AI125453-06
Testing of brequinar in combination with dipyridamole for ClearCreekBio06/15/2021 - 06/30/2022 (PI)
Clear Creek Bio, Inc.
Neutralization and binding of antibody to virus by Regeneron antibodies07/08/2020 - 06/30/2022 (Subcontract PI)
Regeneron Pharmaceuticals, Inc. HHS ASPR BARDAHHSO100201700020C
Structural and Functional Characterization of the Ebola Virus Replication Complex (Core C)07/01/2019 - 06/30/2022 (Subcontract PI)
The Washington University NIH NIAID5P01AI120943-05
Structural and Functional Characterization of the Ebola Virus Replication Complex07/01/2018 - 06/30/2022 (Subcontract PI)
The Washington University NIH NIAID5P01AI120943-05
Emerging virus-host cell protein interaction networks08/01/2018 - 03/31/2022 (Subcontract PI)
Purdue University NIH NIAID5R01AI114814-05
Small molecule inhibitors of Ebola virus polymerase function08/01/2018 - 11/15/2021 (Subcontract PI)
Georgia State University NIH NIAID5R01AI125453-04
HTS for identification and evaluation of efficacy for therapeutics against SARS-CoV-2 infection05/01/2020 - 10/31/2021 (Subcontract PI)
President & Fellows of Harvard College on behalf of Harvard Medical School China Evergrande Gr
Advanced development of a viral entry inhbitor as a therapeutic for arenavirus hemorrhagic fever03/01/2020 - 08/29/2021 (Subcontract PI)
Kineta, Inc. NIH NIAID5R01AI141102-02